Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease
Authors
Keywords
-
Journal
Clinical Journal of the American Society of Nephrology
Volume 15, Issue 9, Pages 1287-1298
Publisher
American Society of Nephrology (ASN)
Online
2020-08-20
DOI
10.2215/cjn.15241219
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Large-Scale Whole-Genome Sequencing Reveals the Genetic Architecture of Primary Membranoproliferative GN and C3 Glomerulopathy
- (2020) Adam P. Levine et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- C3 glomerulopathy — understanding a rare complement-driven renal disease
- (2019) Richard J. H. Smith et al. Nature Reviews Nephrology
- C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial
- (2019) Piero Ruggenenti et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations
- (2019) Fernando Corvillo et al. Frontiers in Immunology
- Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy
- (2018) Moglie Le Quintrec et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy
- (2018) Rupali S. Avasare et al. Clinical Journal of the American Society of Nephrology
- Evolving complexity of complement-related diseases
- (2018) H. Terence Cook CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy
- (2018) Andrew S. Bomback et al. KIDNEY INTERNATIONAL
- C3 glomerulopathy associated with monoclonal Ig is a distinct subtype
- (2018) Aishwarya Ravindran et al. KIDNEY INTERNATIONAL
- Genetic analysis of the complement pathway in C3 glomerulopathy
- (2018) Weiwei Zhao et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic
- (2018) Aishwarya Ravindran et al. MAYO CLINIC PROCEEDINGS
- The role of properdin in complement-mediated renal diseases: a new player in complement-inhibiting therapy?
- (2018) Marloes A. H. M. Michels et al. PEDIATRIC NEPHROLOGY
- Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN
- (2018) Roberta Donadelli et al. Frontiers in Immunology
- Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex–Mediated Membranoproliferative GN
- (2017) Paraskevas Iatropoulos et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The renaissance of complement therapeutics
- (2017) Daniel Ricklin et al. Nature Reviews Nephrology
- Genetics of Immune-Mediated Glomerular Diseases: Focus on Complement
- (2017) Marina Noris et al. SEMINARS IN NEPHROLOGY
- Talking back: the podocytes and endothelial cells duke it out
- (2016) Agnes B. Fogo KIDNEY INTERNATIONAL
- Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome
- (2016) Paraskevas Iatropoulos et al. MOLECULAR IMMUNOLOGY
- Effectiveness of mycophenolate mofetil in C3 glomerulonephritis
- (2015) Cristina Rabasco et al. KIDNEY INTERNATIONAL
- The role of complement in C3 glomerulopathy
- (2015) Peter F. Zipfel et al. MOLECULAR IMMUNOLOGY
- Podocyte dysfunction in atypical haemolytic uraemic syndrome
- (2015) Marina Noris et al. Nature Reviews Nephrology
- Toward a working definition of C3 glomerulopathy by immunofluorescence
- (2013) Jean Hou et al. KIDNEY INTERNATIONAL
- Causes of Alternative Pathway Dysregulation in Dense Deposit Disease
- (2012) Y. Zhang et al. Clinical Journal of the American Society of Nephrology
- Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis
- (2012) A. S. Bomback et al. Clinical Journal of the American Society of Nephrology
- Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies
- (2012) Aude Servais et al. KIDNEY INTERNATIONAL
- Pathogenesis of the C3 glomerulopathies and reclassification of MPGN
- (2012) Andrew S. Bomback et al. Nature Reviews Nephrology
- Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis
- (2011) Mary Anne Dooley et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Anti-Fibrotic Effect of Mycophenolic Acid-Induced Neutral Endopeptidase
- (2010) M. P. Dell'Oglio et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Mycophenolic acid differentially affects dendritic cell maturation induced by tumor necrosis factor-α and lipopolysaccharide through a different modulation of MAPK signaling
- (2010) Delphine Faugaret et al. MOLECULAR IMMUNOLOGY
- C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function
- (2009) F. Bossi et al. BLOOD
- Effects of Mycophenolic Acid on Human Fibroblast Proliferation, Migration and AdhesionIn VitroandIn Vivo
- (2008) C. Morath et al. AMERICAN JOURNAL OF TRANSPLANTATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started